Results 141 to 150 of about 89,651 (269)
Purpose: To compare the outcome of hand-assisted laparoscopic live donor nephrectomy (HLDN) and total laparoscopic live donor nephrectomy (TLDN) in a single center. Methods: The demographics, complications, and outcomes were compared between successfully
LAI, I-RUE;YANG, CHING-YAO;YEH, CHI-CHUAN;TSAI, MENG-KUN;LEE, PO-HUANG +1 more
core
Anemia of inflammation is a highly prevalent secondary anemia complicating chronic inflammatory diseases. Current animal models are categorized into sterile inflammation, disease‐specific, and genetically engineered models, with comparative analysis of their modeling principles, characteristic phenotypes, and translational advantages to elucidate core ...
Jiayi Cheng +4 more
wiley +1 more source
The OR black box in urology: A survey on patient acceptance and confidence in AI‐assisted surgery
Abstract Objectives This study aims to assess patient acceptance of intraoperative video recording with Operating Room (OR) black box technology, characterise consent conditions and use‐case preferences, and identify predictors of patient confidence in artificial intelligence (AI)‐assisted surgery in urological patients.
Julian Risch +12 more
wiley +1 more source
Unusual complication after laparoscopic left nephrectomy for renal tumour: a case report
In splenic rupture after blunt trauma, iatrogenic spleen injury or non-traumatic cases it is essential that the surgeonmakes correct decisions. Conservative treatment must include continual monitoring and repeated, stringent evaluationof the splenic ...
Juan Santiago Azagra +5 more
core
Abstract Objectives This study aimed to evaluate decision regret following robot‐assisted laparoscopic partial nephrectomy (RALPN) for benign small renal masses (SRMs) in patients who did not undergo preoperative renal mass biopsy (RMB) and to assess factors associated with regret and satisfaction with treatment decision‐making. Patients and Methods We
Sarika Nalagatla +9 more
wiley +1 more source
Systematic review of surgery of solitary metastasis post nephrectomy and its survival.
Renal cell Carcinoma is the twelfth most common cancer worldwide with 338000 cases diagnosed in 2012. The recurrence rates after nephrectomy for RCC is about 20-30% and about 40% eventually dying from the cancer progression.
Seshadri Sriprasad +4 more
core
ABSTRACT Background Combination therapy with immune checkpoint inhibitors and tyrosine kinase inhibitors (IO–TKI) is a key treatment option for metastatic renal cell carcinoma (mRCC), but distinguishing immune‐related adverse events (irAEs) from TKI‐related adverse events (TKI‐AEs) is challenging because of overlapping clinical features.
Misato Tomita +11 more
wiley +1 more source
ABSTRACT The objective of this systematic review and meta‐analysis was to evaluate the validity of progression‐free survival (PFS) and the objective response rate (ORR) as surrogate end points for overall survival (OS) in randomized controlled trials (RCTs) of metastatic renal cell carcinoma.
Russell Leong +7 more
wiley +1 more source
SHOX2 contributes to FABP6L upregulation in ccRCC. FABP6L facilitates PTEN–WWP2 association and promotes PTEN ubiquitination. FABP6L‐driven PTEN loss enhances AKT/mTORC1 signalling and tumour growth. FABP6L depletion restores PTEN and increases everolimus sensitivity in preclinical models. Abstract How PTEN function is impaired in clear cell renal cell
Haoming Yin +7 more
wiley +1 more source

